Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 9:44 PM UTC
| NCT Number | NCT07776691 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE3 |
| Target Enrollment | 802 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | October 6, 2026 (1 week ago) |
As of October 19, 2026: Clinical trial NCT07776691 is currently recruiting participants. This phase3 study for ovarian cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07776691 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07776691 was last updated 1 week ago (October 6, 2026). HelloStudys verifies this status automatically.